AS ONE Corporation

7476.T
Medical Distribution
2026/07/31 Updated
Market Cap: $1.1B (¥183.7B)
Stock Price: $16.06 (¥2,578)
Exchange Rate: 1 USD = ¥160.51

Q1 FY2027 Financial Summary

Azwan's first quarter of FY2027 recorded net sales of 30,002 million yen (up 17.0% YoY), operating income of 3,980 million yen (up 17.4% YoY), and net income of 2,853 million yen (up 25.2% YoY).

Importance:
Page Updated: July 31, 2026
IR Disclosure Date: July 31, 2026

Key Figures

  • Net Sales: 30,002 million yen (up 17.0% YoY)
  • Operating Income: 3,980 million yen (up 17.4% YoY)
  • Net Income: 2,853 million yen (up 25.2% YoY)

AI要約

Performance Overview

Azwan's first quarter of FY2027 achieved sales of 30,002 million yen (up 17.0% YoY), operating income of 3,980 million yen (up 17.4% YoY), and net income of 2,853 million yen (up 25.2% YoY), reflecting strong growth in both sales and profits. The sales increase was primarily driven by expanded sales of medical and research equipment, with continued prudent cost management.

Outlook and Investor Impact

Looking ahead, we anticipate continued growth in sales and profits driven by expanding demand in the medical and research sectors. The company plans to strengthen its growth foundation through new product launches and enhanced overseas expansion activities. For investors, this steady performance and strategic growth outlook are expected to increase confidence in medium- to long-term earnings expansion.

Profit Margin Analysis

Segment-wise Revenue Breakdown

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Azwan Corporation

Company overview · Stock price · Financial data · All IR

View company page →